{"id":24725,"date":"2024-02-16T05:44:55","date_gmt":"2024-02-16T05:44:55","guid":{"rendered":"https:\/\/www.fyeo.in\/ultragenic\/?p=24725"},"modified":"2024-02-22T04:49:44","modified_gmt":"2024-02-22T04:49:44","slug":"ultragenic-implements-custom-solution-on-argus-safety-system","status":"publish","type":"post","link":"https:\/\/www.fyeo.in\/ultragenic\/ultragenic-implements-custom-solution-on-argus-safety-system\/","title":{"rendered":"Ultragenic implements custom solution on Argus Safety System 8.4 for a Japan-based global biotechnology company developing precision, cell-targeting investigational therapies in its fight against cancer."},"content":{"rendered":"<section data-vc-full-width=\"true\" data-vc-full-width-init=\"false\" class=\"vc_row wpb_row vc_row-fluid  vc_custom_1617789184205 vc_row-has-fill pofo-stretch-content pofo-stretch-row-container\"><div class=\"wpb_column vc_column_container vc_col-sm-12  col-xs-mobile-fullwidth\"><div class=\"vc_column-inner \"><div class=\"wpb_wrapper\"><\/div><\/div><\/div><\/section><div class=\"vc_row-full-width vc_clearfix\"><\/div><section class=\"vc_row wpb_row vc_row-fluid  vc_custom_1617790463776 position-relative vc_row-has-fill\"><div class=\"wpb_column vc_column_container  col-xs-mobile-fullwidth\"><div class=\"vc_column-inner \"><div class=\"wpb_wrapper\"><div class=\"vc_row wpb_row vc_inner vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-12  col-xs-mobile-fullwidth text-justify\"><div class=\"vc_column-inner \"><div class=\"wpb_wrapper\"><h4 class=\"text-extra-dark-gray margin-20px-bottom font-weight-600 display-inline-block alt-font heading-style2  heading-1\"  style=\"font-size: 30px; line-height: 42px; font-weight: 600; color: #223d77;\" data-fontsize=\"30px\" data-lineheight=\"42px\">Ultragenic implements custom solution on Argus Safety System 8.4 for a Japan-based global biotechnology company developing precision, cell-targeting investigational therapies in its fight against cancer.<\/h4><\/div><\/div><\/div><\/div><div class=\"vc_row wpb_row vc_inner vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-6 vc_col-md-6 col-xs-mobile-fullwidth\"><div class=\"vc_column-inner vc_custom_1680947977479\"><div class=\"wpb_wrapper\"><h6 class=\"text-extra-dark-gray margin-20px-bottom font-weight-600 display-inline-block alt-font heading-style2  heading-2\"  style=\"font-size: 30px; font-weight: 700; color: #223d77;\" data-fontsize=\"30px\">The Challenge<\/h6><div class=\"last-paragraph-no-margin\"><p>The client is a Japan-based global biotechnology company. They are working aggressively towards bringing to market drugs and devices to treat cancer. As a part of their regulatory commitments, the client is required to submit adverse event cases to PDMA (Pharmaceuticals and Medical Devices Agency), the regulatory agency in Japan which reviews quality, safety and efficacy of medical products marketed in the domestic market.<\/p>\n<p>The client had recently upgraded their safety system to Argus 8.4, which provides an out-of-box capability of report submission to PDMA directly from the Argus platform. However, the client needed certain customizations to ensure the depth of information they could submit to the regulatory body was at par with what they had been submitting manually through the PDMA platform.<\/p>\n<\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container vc_col-has-fill vc_col-sm-6 vc_col-md-6 col-xs-mobile-fullwidth\"><div class=\"vc_column-inner vc_custom_1680947991208\"><div class=\"wpb_wrapper\"><h6 class=\"text-extra-dark-gray margin-20px-bottom font-weight-600 display-inline-block alt-font heading-style2  heading-3\"  style=\"font-size: 24px; font-weight: 700; color: #ffffff;\" data-fontsize=\"24px\">Key Deliverables<\/h6><div class=\"last-paragraph-no-margin\" style=\"color: #ffffff;\"><p>As part of the technology customizations to Argus 8.4 requested by the client, we were mandated to deliver the following:<\/p>\n<p style=\"margin-bottom: 15px;\"><strong>\u2022<\/strong> Expand the Nullification Report logic to accept details for each nullification reason<\/p>\n<p style=\"margin-bottom: 15px;\"><strong>\u2022<\/strong> Allow for submission of Concomitant Medical Device details in the E2B reporting within the Argus framework<\/p>\n<p style=\"margin-bottom: 15px;\"><strong>\u2022<\/strong> Build capability to select multiple health codes for every adverse event in the Health Damage Description case reporting through Argus 8.4<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"vc_row wpb_row vc_inner vc_row-fluid  vc_custom_1680947984116\"><div class=\"wpb_column vc_column_container vc_col-sm-12  col-xs-mobile-fullwidth\"><div class=\"vc_column-inner \"><div class=\"wpb_wrapper\"><div class=\"separator-line-horrizontal-full bg-extra-light-gray center-col pofo-separator\" style=\"background-color:#ededed; min-height: 1px; width: 100%;\"><\/div><\/div><\/div><\/div><\/div><div class=\"vc_row wpb_row vc_inner vc_row-fluid  vc_custom_1677645354581\"><div class=\"wpb_column vc_column_container vc_col-sm-12  col-xs-mobile-fullwidth\"><div class=\"vc_column-inner \"><div class=\"wpb_wrapper\"><h6 class=\"text-extra-dark-gray margin-20px-bottom font-weight-600 display-inline-block alt-font heading-style2  heading-4\"  style=\"font-size: 30px; font-weight: 700; color: #223d77;\" data-fontsize=\"30px\">Our Approach (Solution)<\/h6><div class=\"last-paragraph-no-margin\"><p>The client\u2019s team had been using the manual mode of adverse event report submission using the PDMA platform. When they upgraded their safety system to Argus 8.4, they observed that there were certain limitations to the amount of case details they could submit through it, viz a viz the PDMA platform.<\/p>\n<p><strong>\u2022<\/strong> <strong>Nullification reason details submission:<\/strong> Expansion of capabilities to allow a user to enter the nullification reason details after selecting either the pre-defined reason from the drop down, or by selecting \u2018other\u2019 in case the reason was not listed. This ensured that the auto-scheduled nullification XML report contained both, the Nullification reason and Nullification reason details.<\/p>\n<p><strong>\u2022<\/strong> <strong>Concomitant Medical Device information submission:<\/strong> Customisation of the logic for Concomitant Medical Device in the safety system to enable this information to be entered by the user through the PMDA tool within Argus as a feature enhancement.<\/p>\n<p><strong>\u2022<\/strong> <strong>Health Damage Description submission:<\/strong> Expansion of AE Report Submission capability to allow for multiple selections of health impact codes to be made, ensuring that all adverse event causes are captured in the report.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section data-vc-full-width=\"true\" data-vc-full-width-init=\"false\" class=\"vc_row wpb_row vc_row-fluid  vc_custom_1708062933890 vc_row-has-fill pofo-stretch-content pofo-stretch-row-container\"><div class=\"wpb_column vc_column_container vc_col-sm-12  col-xs-mobile-fullwidth\"><div class=\"vc_column-inner vc_custom_1708062957891\"><div class=\"wpb_wrapper\"><h6 class=\"text-extra-dark-gray margin-20px-bottom font-weight-600 display-inline-block alt-font heading-style2  heading-5\"  style=\"font-size: 30px; font-weight: 700; color: #223d77;\" data-fontsize=\"30px\">Client Benefits<\/h6><div class=\"last-paragraph-no-margin\"><p><strong>\u2022 Prevented loss of data:<\/strong> The customizations ensured that the client could submit all the relevant information in the PDMA report submissions through the Argus 8.4 safety system, which they were doing through the manual means on the PDMA platform.<\/p>\n<p><strong>\u2022<\/strong> The customizations we built into the Safety System brought <strong>parity between the external PDMA tool and Argus 8.4 with the added advantage of automation.<\/strong><\/p>\n<p><strong>\u2022<\/strong> Since the submissions were made from within the Argus platform, it ensured <strong>100% accuracy and ease of reporting.<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/section><div class=\"vc_row-full-width vc_clearfix\"><\/div><section class=\"vc_row wpb_row vc_row-fluid  vc_custom_1617793095950\"><div class=\"wpb_column vc_column_container vc_col-sm-12  col-xs-mobile-fullwidth text-center\"><div class=\"vc_column-inner \"><div class=\"wpb_wrapper\"><h6 class=\"text-extra-dark-gray margin-20px-bottom font-weight-600 display-block alt-font heading-style2  heading-6\"  style=\"font-weight: 600; color: #223d77;\">Share this Impact Study<\/h6><div class=\"last-paragraph-no-margin\"><div class=\"sfsi_widget sfsi_shortcode_container\"><div class=\"norm_row sfsi_wDiv \"  style=\"width:325px;text-align:center;\"><div style='width:50px; height:50px;margin-left:15px;margin-bottom:5px; ' class='sfsi_wicons shuffeldiv ' ><div class='inerCnt'><a class=' sficn' data-effect='fade_in' target='_blank'  href='' id='sfsiid_facebook_icon' style='width:50px;height:50px;opacity:0.6;'  ><img data-pin-nopin='true' alt='Facebook' title='Facebook' src='https:\/\/www.fyeo.in\/ultragenic\/wp-content\/plugins\/ultimate-social-media-icons\/images\/icons_theme\/thin\/thin_facebook.png' width='50' height='50' style='' class='sfcm sfsi_wicon ' data-effect='fade_in'   \/><\/a><div class=\"sfsi_tool_tip_2 fb_tool_bdr sfsiTlleft\" style=\"opacity:0;z-index:-1;\" id=\"sfsiid_facebook\"><span class=\"bot_arow bot_fb_arow\"><\/span><div class=\"sfsi_inside\"><div  class='icon2'><div class=\"fb-like\" width=\"200\" data-href=\"https:\/\/www.fyeo.in\/ultragenic\/ultragenic-implements-custom-solution-on-argus-safety-system\/\"  data-send=\"false\" data-layout=\"button_count\" data-action=\"like\"><\/div><\/div><div  class='icon3'><a target='_blank' href='https:\/\/www.facebook.com\/sharer\/sharer.php?u=https%3A%2F%2Fwww.fyeo.in%2Fultragenic%2Fwp-json%2Fwp%2Fv2%2Fposts%2F24725' style='display:inline-block;'  > <img class='sfsi_wicon'  data-pin-nopin='true' alt='fb-share-icon' title='Facebook Share' src='https:\/\/www.fyeo.in\/ultragenic\/wp-content\/plugins\/ultimate-social-media-icons\/images\/share_icons\/fb_icons\/en_US.svg' \/><\/a><\/div><\/div><\/div><\/div><\/div><div style='width:50px; height:50px;margin-left:15px;margin-bottom:5px; ' class='sfsi_wicons shuffeldiv ' ><div class='inerCnt'><a class=' sficn' data-effect='fade_in' target='_blank'  href='' id='sfsiid_twitter_icon' style='width:50px;height:50px;opacity:0.6;'  ><img data-pin-nopin='true' alt='Twitter' title='Twitter' src='https:\/\/www.fyeo.in\/ultragenic\/wp-content\/plugins\/ultimate-social-media-icons\/images\/icons_theme\/thin\/thin_twitter.png' width='50' height='50' style='' class='sfcm sfsi_wicon ' data-effect='fade_in'   \/><\/a><div class=\"sfsi_tool_tip_2 twt_tool_bdr sfsiTlleft\" style=\"opacity:0;z-index:-1;\" id=\"sfsiid_twitter\"><span class=\"bot_arow bot_twt_arow\"><\/span><div class=\"sfsi_inside\"><div  class='icon2'><div class='sf_twiter' style='display: inline-block;vertical-align: middle;width: auto;'>\r\n\t\t\t\t\t\t<a target='_blank' href='https:\/\/x.com\/intent\/post?text=Hey%2C+check+out+this+cool+site+I+found%3A+www.yourname.com+%23Topic+via%40my_twitter_name+https%3A%2F%2Fwww.fyeo.in%2Fultragenic%2Fwp-json%2Fwp%2Fv2%2Fposts%2F24725' style='display:inline-block' >\r\n\t\t\t\t\t\t\t<img data-pin-nopin= true class='sfsi_wicon' src='https:\/\/www.fyeo.in\/ultragenic\/wp-content\/plugins\/ultimate-social-media-icons\/images\/share_icons\/Twitter_Tweet\/en_US_Tweet.svg' alt='Post on X' title='Post on X' >\r\n\t\t\t\t\t\t<\/a>\r\n\t\t\t\t\t<\/div><\/div><\/div><\/div><\/div><\/div><div style='width:50px; height:50px;margin-left:15px;margin-bottom:5px; ' class='sfsi_wicons shuffeldiv ' ><div class='inerCnt'><a class=' sficn' data-effect='fade_in' target='_blank'  href='' id='sfsiid_linkedin_icon' style='width:50px;height:50px;opacity:0.6;'  ><img data-pin-nopin='true' alt='LinkedIn' title='LinkedIn' src='https:\/\/www.fyeo.in\/ultragenic\/wp-content\/plugins\/ultimate-social-media-icons\/images\/icons_theme\/thin\/thin_linkedin.png' width='50' height='50' style='' class='sfcm sfsi_wicon ' data-effect='fade_in'   \/><\/a><div class=\"sfsi_tool_tip_2 linkedin_tool_bdr sfsiTlleft\" style=\"opacity:0;z-index:-1;\" id=\"sfsiid_linkedin\"><span class=\"bot_arow bot_linkedin_arow\"><\/span><div class=\"sfsi_inside\"><div  class='icon2'><a target='_blank' href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https%3A%2F%2Fwww.fyeo.in%2Fultragenic%2Fwp-json%2Fwp%2Fv2%2Fposts%2F24725\"><img decoding=\"async\" class=\"sfsi_wicon\" data-pin-nopin= true alt=\"Share\" title=\"Share\" src=\"https:\/\/www.fyeo.in\/ultragenic\/wp-content\/plugins\/ultimate-social-media-icons\/images\/share_icons\/Linkedin_Share\/en_US_share.svg\" \/><\/a><\/div><\/div><\/div><\/div><\/div><\/div ><div id=\"sfsi_holder\" class=\"sfsi_holders\" style=\"position: relative; float: left;width:100%;z-index:-1;\"><\/div ><script>window.addEventListener(\"sfsi_functions_loaded\", function()\n\t\t\t{\n\t\t\t\tif (typeof sfsi_widget_set == \"function\") {\n\t\t\t\t\tsfsi_widget_set();\n\t\t\t\t}\n\t\t\t}); <\/script><div style=\"clear: both;\"><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/section><section class=\"vc_row wpb_row vc_row-fluid  vc_custom_1617791385843\"><div class=\"wpb_column vc_column_container vc_col-sm-12  col-xs-mobile-fullwidth\"><div class=\"vc_column-inner \"><div class=\"wpb_wrapper\"><div class=\"separator-line-horrizontal-full bg-extra-light-gray center-col pofo-separator\" style=\"background-color:#ededed; min-height: 1px; width: 100%;\"><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>The client is a leading global Contract Research Organization (CRO), providing regulatory, &#8230;<\/p>\n","protected":false},"author":18,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[91],"tags":[],"class_list":["post-24725","post","type-post","status-publish","format-standard","hentry","category-casestudy"],"_links":{"self":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/posts\/24725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/comments?post=24725"}],"version-history":[{"count":6,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/posts\/24725\/revisions"}],"predecessor-version":[{"id":24740,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/posts\/24725\/revisions\/24740"}],"wp:attachment":[{"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/media?parent=24725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/categories?post=24725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyeo.in\/ultragenic\/wp-json\/wp\/v2\/tags?post=24725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}